claim: niclosamide inhibits sars-cov2 entry by blocking internalization through ph-dependent clic/geec endocytic pathway.
evidence_1: niclosamide inhibits sars-cov2 entry by blocking internalization through ph-dependent clic", "here, we demonstrate that the receptor binding domain (rbd) of sars-cov2 is internalized via the clathrin and dynamin-independent, ph-dependent clic/geec (cg) endocytic pathway.")